DocDollars

Novavax Inc

MD · United States · Reporting entity ID 100001281931

Total reported 2019–2025
$92.3M
#102 of 2,960 reporting companies — 0.1% of all reported industry payments
$484K in general payments across 509 records, plus $91.8M in research funding across 7,092 records.

How it breaks down

General payments $484,277
Research funding $91,802,008

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Novavax Inc reported $92.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #102 of 2,960 reporting companies. 99% of that was research funding and 1% general payments such as consulting, speaking, food and travel. 509 general payment records and 7,092 research records were filed.

Common questions about Novavax Inc

How much has Novavax Inc paid US doctors?

Novavax Inc reported $92,286,285 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $484,277 in general payments, $91,802,008 in research funding.

How does Novavax Inc rank among drug and device companies?

It ranks #102 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Novavax Inc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.